TWD

True Wealth Design Portfolio holdings

AUM $327M
1-Year Est. Return 12.18%
This Quarter Est. Return
1 Year Est. Return
+12.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$284M
AUM Growth
+$21.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,879
New
Increased
Reduced
Closed

Top Buys

1 +$10.2M
2 +$10.1M
3 +$7.2M
4
AVUS icon
Avantis US Equity ETF
AVUS
+$2.17M
5
PYLD icon
PIMCO Multi Sector Bond Active ETF
PYLD
+$1.81M

Sector Composition

1 Technology 2.94%
2 Industrials 1.92%
3 Consumer Discretionary 1.41%
4 Financials 1.3%
5 Healthcare 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNZA icon
1726
LanzaTech
LNZA
$31M
$523 ﹤0.01%
+19
GH icon
1727
Guardant Health
GH
$12.5B
$521 ﹤0.01%
10
+1
SNN icon
1728
Smith & Nephew
SNN
$13.8B
$521 ﹤0.01%
17
SUZ icon
1729
Suzano
SUZ
$11.2B
$518 ﹤0.01%
55
+7
NXDT
1730
NexPoint Diversified Real Estate Trust
NXDT
$134M
$516 ﹤0.01%
123
+105
CRVL icon
1731
CorVel
CRVL
$3.73B
$514 ﹤0.01%
5
UBSI icon
1732
United Bankshares
UBSI
$4.89B
$511 ﹤0.01%
14
+12
CACC icon
1733
Credit Acceptance
CACC
$4.87B
$510 ﹤0.01%
1
U icon
1734
Unity
U
$15.7B
$509 ﹤0.01%
21
-728
AMCX icon
1735
AMC Networks
AMCX
$340M
$508 ﹤0.01%
81
+32
EGBN icon
1736
Eagle Bancorp
EGBN
$480M
$507 ﹤0.01%
26
-55
COMM icon
1737
CommScope
COMM
$3.66B
$506 ﹤0.01%
61
+59
GTX icon
1738
Garrett Motion
GTX
$3.2B
$505 ﹤0.01%
48
PLUS icon
1739
ePlus
PLUS
$2.31B
$505 ﹤0.01%
7
-51
GFL icon
1740
GFL Environmental
GFL
$15.9B
$505 ﹤0.01%
10
PRMB
1741
Primo Brands
PRMB
$5.79B
$504 ﹤0.01%
17
+14
FBRT
1742
Franklin BSP Realty Trust
FBRT
$806M
$503 ﹤0.01%
47
+22
ETD icon
1743
Ethan Allen Interiors
ETD
$557M
$502 ﹤0.01%
18
-185
ASTE icon
1744
Astec Industries
ASTE
$1B
$501 ﹤0.01%
12
-61
RAPP
1745
Rapport Therapeutics
RAPP
$1.2B
$501 ﹤0.01%
44
+41
BKU icon
1746
Bankunited
BKU
$2.88B
$499 ﹤0.01%
14
-1
AORT icon
1747
Artivion
AORT
$2.14B
$498 ﹤0.01%
16
+3
CDP icon
1748
COPT Defense Properties
CDP
$3.27B
$497 ﹤0.01%
18
+4
DNA icon
1749
Ginkgo Bioworks
DNA
$487M
$495 ﹤0.01%
44
-4
CTNM
1750
Contineum Therapeutics
CTNM
$311M
$493 ﹤0.01%
+124